Can G Proteins be Targets for Therapeutic Intervention?
Yes, G proteins are potential targets for drug development. Given their central role in signal transduction, targeting G proteins or their associated pathways can help mitigate the effects of toxins. For example, developing antagonists or agonists that can modulate GPCR activity provides a means to counteract toxin-induced signaling imbalances.
